Research

caprotec bioanalytics Announces the Successful Completion of a Collaborative Research Project with Roche

caprotec bioanalytics GmbH has successfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound Mass Spectrometry) technology to analyze the binding characteristics and interaction of one undisclosed drug candidate with its human target proteins.

Gene Therapy a step Closer to Mass Production

Researchers in Latvia and Finland have synthesised and studied a range of organic compounds able to carry genetic material into individual cells where it can remedy the diseases caused by defective genes. Still under development, these compounds are much more readily produced than the viral carriers now in use and avoid their side-effects. Most importantly, they are much more effective than other organic carrier substances developed so far.

Frost & Sullivan's analysts comment on India’s plan to invest in the Russian pharmaceutical industry

India is ready to invest in the Russian pharmaceutical industry, including India-Russia joint ventures, as India's Commerce and Industry Minister, Anand Sharma, said during his visit to Russia last week. Among other resources and technologies, India is very keen in developing biotechnologies, nanotechnologies and other sciences such as genomics and bioinformatics, thereby entering the Russian healthcare industry.

The IT @ Networking Awards 2010 - Open Competition for Healthcare IT Solutions

The IT @ Networking Awards 2010 (IT @ 2010) is an open competition for fully implemented, operable healthcare IT solutions. The goal is to raise awareness of some of the world's finest and most innovative local, regional and national healthcare IT projects.

Building the perfect cornea from scratch, the EU way

A team of European small and medium-sized enterprises (SMEs) together with scientists have developed an artificial cornea that could allow blind people to see, and save patients from the serious drawbacks of the conventional transplant method currently in use. So far, surgeons have been transplanting corneas from human donors. These companies have teamed up with public research institutes to build the perfect, high-tech prosthetic cornea.

New Biotech Alliance in Saxony to Secure Growth and Jobs

"Today marks the start of a new era for Saxony as a stronghold of biotechnology," declared Roland Göhde, the President of registered association biosaxony e.V. and CEO of Partec GmbH from Görlitz, speaking on the successful merger of the two organizations biodresden e.V. and biosaxony e.V. Players in the biotech and life sciences sector throughout Saxony (Germany) will now be uniting their activities within the new joint association. After the members of biodresden e.V. had unanimously backed the merger on June 4, the decision was finally approved by the membership of biosaxony e.V. on June 10 in Leipzig.

Elsevier acquires Collexis

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.

Research & Development

caprotec bioanalytics Announces the Successful Completion of a Collaborative Research Project with Roche

Gene Therapy a step Closer to Mass Production

Frost & Sullivan's analysts comment on India’s plan to invest in the Russian pharmaceutical industry

The IT @ Networking Awards 2010 - Open Competition for Healthcare IT Solutions

Building the perfect cornea from scratch, the EU way

New Biotech Alliance in Saxony to Secure Growth and Jobs

Elsevier acquires Collexis

More Pharma News ...